The Ensign Group, Inc. (ENSG)
USD 128.35
(-1.5%)
USD 128.35
(-1.5%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 255.36 Million USD | -13.97% |
| 2022 | 296.82 Million USD | 13.96% |
| 2021 | 260.46 Million USD | 16.72% |
| 2020 | 223.15 Million USD | 72.75% |
| 2019 | 129.18 Million USD | 0.54% |
| 2018 | 128.48 Million USD | 58.07% |
| 2017 | 81.28 Million USD | -11.5% |
| 2016 | 91.84 Million USD | -1.33% |
| 2015 | 93.08 Million USD | 27.64% |
| 2014 | 72.92 Million USD | 25.86% |
| 2013 | 57.94 Million USD | -23.81% |
| 2012 | 76.04 Million USD | -16.15% |
| 2011 | 90.69 Million USD | 19.88% |
| 2010 | 75.65 Million USD | 28.36% |
| 2009 | 58.93 Million USD | 21.13% |
| 2008 | 48.65 Million USD | 32.51% |
| 2007 | 36.71 Million USD | -5.59% |
| 2006 | 38.89 Million USD | 21.59% |
| 2005 | 31.98 Million USD | -86.92% |
| 2004 | 244.53 Million USD | 1930.02% |
| 2003 | 12.04 Million USD | 103.62% |
| 2002 | 5.91 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 86.13 Million USD | 56.42% |
| 2024 Q1 | 55.06 Million USD | 141.25% |
| 2024 Q3 | 89.33 Million USD | 3.72% |
| 2023 Q1 | 74.87 Million USD | -0.43% |
| 2023 Q3 | 79.79 Million USD | 2.46% |
| 2023 Q4 | 22.82 Million USD | -71.39% |
| 2023 Q2 | 77.87 Million USD | 4.01% |
| 2023 FY | 255.36 Million USD | -13.97% |
| 2022 Q1 | 69.11 Million USD | 5.33% |
| 2022 Q4 | 75.19 Million USD | 1.22% |
| 2022 FY | 296.82 Million USD | 13.96% |
| 2022 Q3 | 74.28 Million USD | -5.04% |
| 2022 Q2 | 78.23 Million USD | 13.2% |
| 2021 Q4 | 65.61 Million USD | -1.06% |
| 2021 FY | 260.46 Million USD | 16.72% |
| 2021 Q1 | 63.67 Million USD | 14.0% |
| 2021 Q2 | 64.85 Million USD | 1.85% |
| 2021 Q3 | 66.31 Million USD | 2.26% |
| 2020 FY | 223.15 Million USD | 72.75% |
| 2020 Q1 | 56.79 Million USD | 43.08% |
| 2020 Q4 | 55.85 Million USD | 1.43% |
| 2020 Q3 | 55.06 Million USD | -0.66% |
| 2020 Q2 | 55.43 Million USD | -2.39% |
| 2019 Q3 | 38.94 Million USD | 2.9% |
| 2019 Q4 | 39.69 Million USD | 1.92% |
| 2019 FY | 129.18 Million USD | 0.54% |
| 2019 Q1 | 37.8 Million USD | 9.75% |
| 2019 Q2 | 37.84 Million USD | 0.11% |
| 2018 FY | 128.48 Million USD | 58.07% |
| 2018 Q3 | 29.28 Million USD | -7.83% |
| 2018 Q2 | 31.77 Million USD | -3.65% |
| 2018 Q4 | 34.44 Million USD | 17.62% |
| 2018 Q1 | 32.97 Million USD | 26.15% |
| 2017 Q4 | 26.14 Million USD | 2.28% |
| 2017 FY | 81.28 Million USD | -11.5% |
| 2017 Q3 | 25.55 Million USD | 16.01% |
| 2017 Q1 | 7.55 Million USD | -78.84% |
| 2017 Q2 | 22.03 Million USD | 191.72% |
| 2016 Q2 | 19.8 Million USD | 21.42% |
| 2016 Q1 | 16.31 Million USD | -32.96% |
| 2016 Q3 | 20.04 Million USD | 1.17% |
| 2016 FY | 91.84 Million USD | -1.33% |
| 2016 Q4 | 35.68 Million USD | 78.06% |
| 2015 FY | 93.08 Million USD | 27.64% |
| 2015 Q3 | 21.58 Million USD | -1.8% |
| 2015 Q2 | 21.98 Million USD | -12.67% |
| 2015 Q1 | 25.17 Million USD | 28.18% |
| 2015 Q4 | 24.33 Million USD | 12.73% |
| 2014 Q4 | 19.64 Million USD | 28.41% |
| 2014 Q1 | 24.34 Million USD | -3.06% |
| 2014 Q2 | 13.64 Million USD | -43.97% |
| 2014 FY | 72.92 Million USD | 25.86% |
| 2014 Q3 | 15.29 Million USD | 12.12% |
| 2013 Q3 | 20.28 Million USD | -12.89% |
| 2013 Q2 | 23.29 Million USD | 316.59% |
| 2013 FY | 57.94 Million USD | -23.81% |
| 2013 Q4 | 25.11 Million USD | 23.79% |
| 2013 Q1 | -10.75 Million USD | -283.05% |
| 2012 FY | 76.04 Million USD | -16.15% |
| 2012 Q1 | 23.38 Million USD | 23.42% |
| 2012 Q2 | 23.16 Million USD | -0.97% |
| 2012 Q3 | 23.62 Million USD | 1.98% |
| 2012 Q4 | 5.87 Million USD | -75.13% |
| 2011 Q1 | 23.71 Million USD | 11.41% |
| 2011 Q2 | 24.11 Million USD | 1.71% |
| 2011 Q4 | 18.95 Million USD | -20.76% |
| 2011 FY | 90.69 Million USD | 19.88% |
| 2011 Q3 | 23.91 Million USD | -0.84% |
| 2010 Q1 | 17.68 Million USD | 9.79% |
| 2010 Q4 | 21.28 Million USD | 14.5% |
| 2010 FY | 75.65 Million USD | 28.36% |
| 2010 Q3 | 18.58 Million USD | 2.74% |
| 2010 Q2 | 18.09 Million USD | 2.3% |
| 2009 Q2 | 14.53 Million USD | 0.55% |
| 2009 Q1 | 14.45 Million USD | 3.54% |
| 2009 Q3 | 13.83 Million USD | -4.86% |
| 2009 Q4 | 16.11 Million USD | 16.48% |
| 2009 FY | 58.93 Million USD | 21.13% |
| 2008 Q1 | 11.26 Million USD | 5.18% |
| 2008 Q4 | 13.96 Million USD | 18.0% |
| 2008 Q3 | 11.83 Million USD | 2.08% |
| 2008 Q2 | 11.59 Million USD | 2.92% |
| 2008 FY | 48.65 Million USD | 32.51% |
| 2007 Q4 | 10.7 Million USD | 35.11% |
| 2007 Q3 | 7.92 Million USD | -23.68% |
| 2007 Q1 | 7.69 Million USD | 103.35% |
| 2007 FY | 36.71 Million USD | -5.59% |
| 2007 Q2 | 10.38 Million USD | 34.91% |
| 2006 Q1 | 89.64 Million USD | 146.29% |
| 2006 Q2 | 89.64 Million USD | 0.0% |
| 2006 Q3 | 89.64 Million USD | 0.0% |
| 2006 FY | 38.89 Million USD | 21.59% |
| 2006 Q4 | -230.03 Million USD | -356.61% |
| 2005 FY | 31.98 Million USD | -86.92% |
| 2005 Q3 | 75.21 Million USD | 0.0% |
| 2005 Q4 | -193.65 Million USD | -357.47% |
| 2005 Q2 | 75.21 Million USD | 0.0% |
| 2005 Q1 | 75.21 Million USD | 0.0% |
| 2004 FY | 244.53 Million USD | 1930.02% |
| 2003 FY | 12.04 Million USD | 103.62% |
| 2002 FY | 5.91 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 506.59 Million USD | 49.592% |
| Addus HomeCare Corporation | 90.95 Million USD | -180.759% |
| AirSculpt Technologies, Inc. | 9.48 Million USD | -2592.893% |
| Amedisys, Inc. | 156.39 Million USD | -63.284% |
| American Oncology Network, Inc. | -49.15 Million USD | 619.524% |
| Astrana Health, Inc. | 84.61 Million USD | -201.806% |
| Aveanna Healthcare Holdings Inc. | 8.07 Million USD | -3063.615% |
| IMAC Holdings, Inc. | -6.37 Million USD | 4105.438% |
| biote Corp. | 28.65 Million USD | -791.116% |
| Cryo-Cell International, Inc. | -12.3 Million USD | 2175.474% |
| Cross Country Healthcare, Inc. | 112.71 Million USD | -126.564% |
| COMPASS Pathways plc | -136.91 Million USD | 286.51% |
| DocGo Inc. | 15.05 Million USD | -1596.229% |
| Healthcare Services Group, Inc. | 62.35 Million USD | -309.518% |
| InnovAge Holding Corp. | -23.18 Million USD | 1201.67% |
| Assure Holdings Corp. | -20.08 Million USD | 1371.621% |
| The Joint Corp. | -2.07 Million USD | 12418.2% |
| LifeStance Health Group, Inc. | -189.13 Million USD | 235.019% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.7 Million USD | 1726.154% |
| ModivCare Inc. | -139.94 Million USD | 282.475% |
| NewGenIvf Group Limited | 42.24 Thousand USD | -604433.403% |
| Novo Integrated Sciences, Inc. | -8.55 Million USD | 3085.644% |
| Option Care Health, Inc. | 314.59 Million USD | 18.827% |
| P3 Health Partners Inc. | -167.86 Million USD | 252.131% |
| P3 Health Partners Inc. | -167.86 Million USD | 252.131% |
| The Pennant Group, Inc. | 25.16 Million USD | -914.609% |
| Surgery Partners, Inc. | 328 Million USD | 22.144% |
| Syra Health Corp. Class A Common Stock | -2.88 Million USD | 8943.576% |
| Talkspace, Inc. | -23.2 Million USD | 1200.293% |
| Talkspace, Inc. | -23.2 Million USD | 1200.293% |
| The Oncology Institute, Inc. | -77.01 Million USD | 431.568% |
| The Oncology Institute, Inc. | -77.01 Million USD | 431.568% |